<DOC>
	<DOCNO>NCT02769247</DOCNO>
	<brief_summary>To compare efficacy intrauterine lidocaine oral naproxen sodium discomfort pain patient undergoing intrauterine device insertion .</brief_summary>
	<brief_title>Efficacy Intrauterine Lidocaine Naproxen Pain Control With Intrauterine Device Insertion</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled study woman recruit outpatient obstetrics gynecology clinic . Women desire intrauterine device insertion invite participate . The investigator plan recruit woman desire intrauterine device insertion one four group : A : placebo/normal saline infusion ; B : placebo/lidocaine infusion ; C : Saline infusion/ naproxen ; D : lidocaine infusion/ naproxen .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>DEERSeligible reproductive age woman ( i.e . Tricare beneficiary ) age 18 year old desire Paragard Mirena intrauterine device insertion Current pregnancy cervical stenosis severe medical illness know allergy sensitivity lidocaine naproxen peptic ulcer disease current pelvic inflammatory disease patient know renal insufficiency patient use chronic NSAIDs chronic pain medication woman desire Skyla IUD insertion also exclude due infrequency insertion WRNMMC</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>naproxen</keyword>
	<keyword>lidocaine</keyword>
	<keyword>intrauterine device</keyword>
	<keyword>IUD</keyword>
	<keyword>pain</keyword>
</DOC>